Home NDC 26637-712 Cefpodoxime Proxetil
Product NDC 26637-712
11-digit product format 266370712
Labeler code 26637
Product ID 26637-712_85ac23fc-3642-4d37-af32-f0d36ab61882
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Cefpodoxime Proxetil
Dosage form TABLET, FILM COATED
Route ORAL
Labeler Putney Inc
Application ANDA065462
Marketing category ANDA
Marketing start 2008-05-28
Marketing end 2020-12-31
Substance CEFPODOXIME PROXETIL
Active strength 200 mg/1
Pharmacologic classes Cephalosporin Antibacterial [EPC],Cephalosporins [CS]
NDC exclude flag No
Listing certified through 0000-00-00
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 24 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Package NDC Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 excluded product product d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 26637-712-10 d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 excluded product product f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 26637-712-10 f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 excluded product product 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 26637-712-10 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 excluded product product a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 26637-712-10 a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 excluded product product cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 26637-712-10 cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 excluded product product cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 26637-712-10 cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 excluded product product 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 26637-712-10 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 excluded product product ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 26637-712-10 ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 excluded product product 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 26637-712-10 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 excluded product product ad56d346431e…cc804d4bbf1e…2024-11-09 02:27 UTC · source 2024-11-08 excluded package package 26637-712-10 ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 excluded product product 367a005e9d99…383a685ebd0f…2024-10-04 04:10 UTC · source 2024-10-03 excluded package package 26637-712-10 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 excluded product product 557ba5c1ecfa…9c80585c8c6e…2024-07-10 04:00 UTC · source 2024-07-09 excluded package package 26637-712-10 557ba5c1ecfa…9c80585c8c6e…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 42 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A065462-001 CEFPODOXIME PROXETIL CEFPODOXIME PROXETIL EQ 100MG BASE TABLET / ORAL AB 2008-05-28 A065462-002 CEFPODOXIME PROXETIL CEFPODOXIME PROXETIL EQ 200MG BASE TABLET / ORAL AB RS 2008-05-28
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 2 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 3 · 84 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-08-18 06:07:40 2026-07 A065462-001 CEFPODOXIME PROXETIL EQ 100MG BASE TABLET / ORAL AB 2008-05-28 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A065462-002 CEFPODOXIME PROXETIL EQ 200MG BASE TABLET / ORAL AB RS 2008-05-28 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 A065462-001 CEFPODOXIME PROXETIL EQ 100MG BASE TABLET / ORAL AB 2008-05-28 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A065462-002 CEFPODOXIME PROXETIL EQ 200MG BASE TABLET / ORAL AB RS 2008-05-28 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A065462-001 CEFPODOXIME PROXETIL EQ 100MG BASE TABLET / ORAL AB 2008-05-28 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A065462-002 CEFPODOXIME PROXETIL EQ 200MG BASE TABLET / ORAL AB RS 2008-05-28 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A065462-001 CEFPODOXIME PROXETIL EQ 100MG BASE TABLET / ORAL AB 2008-05-28 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A065462-002 CEFPODOXIME PROXETIL EQ 200MG BASE TABLET / ORAL AB RS 2008-05-28 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A065462-001 CEFPODOXIME PROXETIL EQ 100MG BASE TABLET / ORAL AB 2008-05-28 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A065462-002 CEFPODOXIME PROXETIL EQ 200MG BASE TABLET / ORAL AB RS 2008-05-28 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A065462-001 CEFPODOXIME PROXETIL EQ 100MG BASE TABLET / ORAL AB 2008-05-28 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A065462-002 CEFPODOXIME PROXETIL EQ 200MG BASE TABLET / ORAL AB RS 2008-05-28 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A065462-001 CEFPODOXIME PROXETIL EQ 100MG BASE TABLET / ORAL AB 2008-05-28 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A065462-002 CEFPODOXIME PROXETIL EQ 200MG BASE TABLET / ORAL AB RS 2008-05-28 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A065462-001 CEFPODOXIME PROXETIL EQ 100MG BASE TABLET / ORAL AB 2008-05-28 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A065462-002 CEFPODOXIME PROXETIL EQ 200MG BASE TABLET / ORAL AB RS 2008-05-28 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A065462-001 CEFPODOXIME PROXETIL EQ 100MG BASE TABLET / ORAL AB 2008-05-28 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A065462-002 CEFPODOXIME PROXETIL EQ 200MG BASE TABLET / ORAL AB RS 2008-05-28 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A065462-001 CEFPODOXIME PROXETIL EQ 100MG BASE TABLET / ORAL AB 2008-05-28 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A065462-002 CEFPODOXIME PROXETIL EQ 200MG BASE TABLET / ORAL AB RS 2008-05-28 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A065462-001 CEFPODOXIME PROXETIL EQ 100MG BASE TABLET / ORAL AB 2008-05-28 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A065462-002 CEFPODOXIME PROXETIL EQ 200MG BASE TABLET / ORAL AB RS 2008-05-28 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A065462-001 CEFPODOXIME PROXETIL EQ 100MG BASE TABLET / ORAL AB 2008-05-28 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A065462-002 CEFPODOXIME PROXETIL EQ 200MG BASE TABLET / ORAL AB RS 2008-05-28 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A065462-001 CEFPODOXIME PROXETIL EQ 100MG BASE TABLET / ORAL AB 2008-05-28 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A065462-002 CEFPODOXIME PROXETIL EQ 200MG BASE TABLET / ORAL AB RS 2008-05-28 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A065462-001 CEFPODOXIME PROXETIL EQ 100MG BASE TABLET / ORAL AB 2008-05-28 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A065462-002 CEFPODOXIME PROXETIL EQ 200MG BASE TABLET / ORAL AB RS 2008-05-28 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 A065462-001 CEFPODOXIME PROXETIL EQ 100MG BASE TABLET / ORAL AB 2008-05-28 8072bd15b7f6…2024-05-31 18:47 UTC 2024-05 A065462-002 CEFPODOXIME PROXETIL EQ 200MG BASE TABLET / ORAL AB RS 2008-05-28 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A065462-001 CEFPODOXIME PROXETIL EQ 100MG BASE TABLET / ORAL AB 2008-05-28 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A065462-002 CEFPODOXIME PROXETIL EQ 200MG BASE TABLET / ORAL AB RS 2008-05-28 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 A065462-001 CEFPODOXIME PROXETIL EQ 100MG BASE TABLET / ORAL AB 2008-05-28 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 A065462-002 CEFPODOXIME PROXETIL EQ 200MG BASE TABLET / ORAL AB RS 2008-05-28 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 A065462-001 CEFPODOXIME PROXETIL EQ 100MG BASE TABLET / ORAL AB 2008-05-28 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 A065462-002 CEFPODOXIME PROXETIL EQ 200MG BASE TABLET / ORAL AB RS 2008-05-28 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 A065462-001 CEFPODOXIME PROXETIL EQ 100MG BASE TABLET / ORAL AB 2008-05-28 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 A065462-002 CEFPODOXIME PROXETIL EQ 200MG BASE TABLET / ORAL AB RS 2008-05-28 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 A065462-001 CEFPODOXIME PROXETIL EQ 100MG BASE TABLET / ORAL AB 2008-05-28 bb7c543d1eb4…2022-03-09 01:35 UTC 2022-03 A065462-002 CEFPODOXIME PROXETIL EQ 200MG BASE TABLET / ORAL AB RS 2008-05-28 bb7c543d1eb4…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 3 · 84 observed states.
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded CEFPODOXIME PROXETIL ACTIVE INGREDIENT 2TB00A1Z7N CEFPODOXIME PROXETIL TABLET, FILM COATED [PUTNEY INC] 12 CEFPODOXIME ACTIVE MOIETY 7R4F94TVGY CEFPODOXIME PROXETIL TABLET, FILM COATED [PUTNEY INC] 12 CARBOXYMETHYLCELLULOSE CALCIUM INACTIVE INGREDIENT UTY7PDF93L CEFPODOXIME PROXETIL TABLET, FILM COATED [PUTNEY INC] 12 CROSPOVIDONE INACTIVE INGREDIENT 68401960MK CEFPODOXIME PROXETIL TABLET, FILM COATED [PUTNEY INC] 12 FD&C YELLOW NO. 6 INACTIVE INGREDIENT H77VEI93A8 CEFPODOXIME PROXETIL TABLET, FILM COATED [PUTNEY INC] 12 HYDROXYPROPYL CELLULOSE (TYPE H) INACTIVE INGREDIENT RFW2ET671P CEFPODOXIME PROXETIL TABLET, FILM COATED [PUTNEY INC] 12 HYPROMELLOSES INACTIVE INGREDIENT 3NXW29V3WO CEFPODOXIME PROXETIL TABLET, FILM COATED [PUTNEY INC] 12 LACTOSE MONOHYDRATE INACTIVE INGREDIENT EWQ57Q8I5X CEFPODOXIME PROXETIL TABLET, FILM COATED [PUTNEY INC] 12 MAGNESIUM STEARATE INACTIVE INGREDIENT 70097M6I30 CEFPODOXIME PROXETIL TABLET, FILM COATED [PUTNEY INC] 12 SODIUM LAURYL SULFATE INACTIVE INGREDIENT 368GB5141J CEFPODOXIME PROXETIL TABLET, FILM COATED [PUTNEY INC] 12 TALC INACTIVE INGREDIENT 7SEV7J4R1U CEFPODOXIME PROXETIL TABLET, FILM COATED [PUTNEY INC] 12 TITANIUM DIOXIDE INACTIVE INGREDIENT 15FIX9V2JP CEFPODOXIME PROXETIL TABLET, FILM COATED [PUTNEY INC] 12
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.